<DOC>
	<DOCNO>NCT02172963</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy use placenta derive decidual stromal cell therapy hemorrhagic cystitis allogeneic hematopoietic cell transplantation . It hypothesize decidual stromal cell therapy safe infuse positive clinical effect .</brief_summary>
	<brief_title>A Pilot Study Using Placenta Derived Decidual Stromal Cells Hemorrhagic Cystitis</brief_title>
	<detailed_description>Patients grade 2-4 hemorrhagic cystitis receive decidual stromal cell therapy approximately 1-2x10^6 cells/kg weekly interval dependent clinical effect .</detailed_description>
	<mesh_term>Cystitis</mesh_term>
	<criteria>Hemorrhagic cystitis grade 24 Urinary urge without macroscopic hematuria clot</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Stem Cell Transplantation</keyword>
	<keyword>Decidual Stromal Cells</keyword>
</DOC>